Uterine (Endometral) Cancer
Updated: 12/27/2005
References
Abulafia O, Triest WE, et al. Angiogenesis in endometrial hyperplasia
and stage I endometrial carcinoma. Obstet Gynecol. 1995 Oct;86(pt
1):479-85.
American College of Obstetricians and Gynecologists. ACOG educational
bulletin. Osteoporosis. Number 246, April 1998 (replaces No. 167, May
1992). American College of Obstetricians and Gynecologists. Int J
Gynaecol Obstet. 1998 Aug;62(2):193-201.
Alberts DS, Jiang C, et al. Long-term follow-up of a phase II trial
of oral altretamine for consolidation of clinical complete remission in
women with stage III epithelial ovarian cancer in the Southwest Oncology
Group. Int J Gynecol Cancer. 2004 Mar-Apr;14(2):224-28.
Alcain FJ, Buron MI. Ascorbate on cell growth and differentiation. J
Bioenerg Biomembr. 1994 Aug;26(4):393-98.
Apgar BS, Greenberg G. Using progestins in clinical practice. Am
Fam Physician. 2000 Oct 15;62(8):1839-50.
Armstrong B. Endocrine factors in human carcinogenesis. IARC Sci
Publ . 1982;39:193-221.
Ayoub J, udet-Lapointe P, et al. Efficacy of sequential cyclical hormonal
therapy in endometrial cancer and its correlation with steroid hormone
receptor status. Gynecol Oncol. 1988 Oct;31(2):327-37.
Banno K, Susumu N, et al. Association of HNPCC and endometrial cancers. Int
J Clin Oncol. 2004 Aug;9(4):262-69.
Barrenetxe J, Delagrange P, et al. Physiological and metabolic functions
of melatonin. J Physiol Biochem. 2004 Mar;60(1):61-72.
Benagiano G, Primiero FM, et al. Clinical profile of contraceptive progestins. Eur
J Contracept Reprod Health Care. 2004 Sep;9(3):182-93.
Berek JS, Hacker NF. Practical Gynecologic Oncology. 3rd edition.
Hagerstown , Md : Lippincott Williams & Wilkins; 2000.
Bergeron C. Effect of estrogens and antiestrogens on the endometrium. Gynecol
Obstet Fertil. 2002 Dec;30(12):933-37.
Bernstein L, Ross RK, et al. Relationship of hormone use to cancer risk. J
Natl Cancer Inst Monogr. 1992;12:137-47.
Berstein L, Tsyrlina E, et al. Switching (overtargeting) of estrogen
effects and its potential role in hormonal carcinogenesis. Neoplasma.
2002;49(1):21-5.
Bespalov VG, Alexandrov VA, et al. Chemoprevention of mammary, cervix
and nervous system carcinogenesis in animals using cultured Panax ginseng
drugs and preliminary clinical trials in patients with precancerous lesions
of the esophagus and endometrium. J Korean Med Sci. 2001 Dec;16(suppl):S42-S53.
Block KI, Mead MN . Vitamin C in alternative cancer treatment: historical
background. Integr Cancer Ther. 2003 Jun;2(2):147-54.
Bokhman I, Stoliarova IV, et al. Effect of adjuvant hormonotherapy on
the results of the radiation treatment of patients with cancer of the
corpus uteri. Vopr Onkol. 1987;33(4):49-52.
Brooks JD, Ward WE, et al. Supplementation with flaxseed alters estrogen
metabolism in postmenopausal women to a greater extent than does supplementation
with an equal amount of soy. Am J Clin Nutr. 2004 Feb;79(2):318-25.
Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004 Aug 23;23(38):6365-78.
Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment
of cancer: reevaluation of prolongation of survival times in terminal
human cancer. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4538-42.
Cancer and Steroid Hormone Study. Combination oral contraceptive use
and the risk of endometrial cancer. The Cancer and Steroid Hormone Study
of the Centers for Disease Control and the National Institute of Child
Health and Human Development. JAMA. 1987 Feb 13;257(6):796-800.
Carter CA, Pogribny M, et al. Effects of retinoic acid on cell differentiation
and reversion toward normal in human endometrial adenocarcinoma (RL95-2)
cells. Anticancer Res. 1996 Jan;16(1):17-24.
Cassidy A. Potential risks and benefits of phytoestrogen-rich diets. Int
J Vitam Nutr Res. 2003;73(2):120-6.
Chase JE, Gidal BE. Melatonin: therapeutic use in sleep disorders. Ann
Pharmacother. 1997 Oct;31(10):1218-26.
Chen LM, McGonigle KF, et al. Endometrial cancer: recent developments
in evaluation and treatment. Oncology ( Williston Park ) .
1999 Dec;13(12):1665-70.
Chiaffarino F, Parazzini F, et al. Diet and uterine myomas. Obstet
Gynecol. 1999;94(3):395-98.
Chubak J, Tworoger SS, et al. Associations between reproductive and
menstrual factors and postmenopausal sex hormone concentrations. Cancer
Epidemiol Biomarkers Prev. 2004;13(8):1296-1301.
Connell PP, Rotmensch J, et al. Race and clinical outcome in endometrial
carcinoma. Obstet Gynecol. 1999 Nov;94(pt 1):713-20.
Creasman WT. Prognostic significance of hormone receptors in endometrial
cancer. Cancer. 1993 Feb 15;71(suppl 4):1467-70.
Cunzhi H, Jiexian J, et al. Serum and tissue levels of six trace elements
and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biol
Trace Elem Res. 2003;94(2):113-22.
Dai D, Albitar L, et al. A therapeutic model for advanced endometrial
cancer: systemic progestin in combination with local adenoviral-mediated
progesterone receptor expression. Mol Cancer Ther. 2005;4(1):169-75.
Dai D, Wolf DM, et al. Progesterone inhibits human endometrial cancer
cell growth and invasiveness: down-regulation of cellular adhesion molecules
through progesterone B receptors. Cancer Res. 2002 Feb 1;62(3):881-6.
De Loecker W, Janssens J, et al. Effects of sodium ascorbate (vitamin
C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor
cell growth in vitro, II: synergism with combined chemotherapy action. Anticancer
Res. 1993 Jan;13(1):103-6.
Deslypere JP. Obesity and cancer. Metabolism. 1995 Sep;44(suppl
3):24-27.
Dietl J. Actual aspects of endometrial carcinoma. Zentralbl Gynakol.
2002 Jul;124(7):356-61.
Doherty JA, Weiss NS , et al. Genetic factors in catechol estrogen metabolism
in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers
Prev. 2005;14(2):357-66.
Dolberg OT, Hirschmann S, et al. Melatonin for the treatment of sleep
disturbances in major depressive disorder. Am J Psychiatry. 1998
Aug;155(8):1119-21.
Doll R. The lessons of life: keynote address to the nutrition and cancer
conference. Cancer Res. 1992 Apr 1;52(suppl 7):2024s-2029s.
Drozdz M, Tomala J, et al. Concentration of selenium and vitamin E in
the serum of women with malignant genital neoplasms and their family members. Ginekol
Pol. 1989;60(6):301-5.
Ehrlich CE, Young PC, et al. Steroid receptors and clinical outcome
in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol.
1988 Apr;158(4):796-807.
Emons G, Huschmand-Nia A, et al. Hormone replacement therapy and endometrial
cancer. Onkologie. 2004;27(2):207-10.
Friberg LG, Noren H. Prognostic value of steroid hormone receptors for
5-year survival in stage II endometrial cancer. Cancer. 1993
Jun 1;71(11):3570-4.
Fujimoto J, Sakaguchi H, et al. Inhibitory effect of ginsenoside-Rb2
on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur
J Gynaecol Oncol. 2001;22(5):339-41.
Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years
of age or younger. Obstet Gynecol. 1984 Sep;64(3):417-20.
Ginseng- HCC Chemopreventive Study Osaka Group. Study on chemoprevention
of hepatocellular carcinoma by ginseng: an introduction to the protocol. J
Korean Med Sci. 2001 Dec;16(suppl):S70-S74.
Golde DW. Vitamin C in cancer. Integr Cancer Ther. 2003 Jun;2(2):158-59.
Gonzalez MJ, Miranda-Massari JR, et al. Orthomolecular oncology review:
ascorbic acid and cancer 25 years later. Integr Cancer Ther.
2005 Mar;4(1):32-44.
Goodman MT , Hankin JH, et al. Diet, body size, physical activity, and
the risk of endometrial cancer. Cancer Res. 1997;57(22):5077-85.
Goodman MT , Wilkens LR, et al. Association of soy and fiber consumption
with the risk of endometrial cancer. Am J Epidemiol. 1997;146(4):294-306.
Grady D, Gebretsadik T, et al. Hormone replacement therapy and endometrial
cancer risk: a meta-analysis. Obstet Gynecol. 1995 Feb;85(2):304-13.
Greenlee RT, Hill-Harmon MB , et al. Cancer statistics: 2001. CA
Cancer J Clin. 2001 Jan;51(1):15-36.
Gurpide E. Hormone receptors in endometrial cancer. Cancer.
1981 Jul 15;48(suppl 2):638-41.
Hardiman P, Pillay OC, et al. Polycystic ovary syndrome and endometrial
carcinoma. Lancet. 2003 May 24;361(9371):1810-2.
Head KA. Ascorbic acid in the prevention and treatment of cancer. Altern
Med Rev. 1998 Jun;3(3):174-86.
Henderson BE, Casagrande JT, et al. The epidemiology of endometrial
cancer in young women. Br J Cancer. 1983 Jun;47(6):749-56.
Hershcopf RJ, Bradlow HL. Obesity, diet, endogenous estrogens, and the
risk of hormone-sensitive cancer. Am J Clin Nutr. 1987 Jan;45(suppl
1):283-9.
Hill HA, Austin H. Nutrition and endometrial cancer. Cancer Causes
Control. 1996 Jan;7(1):19-32.
Hill HA, Eley JW, et al. Racial differences in endometrial cancer survival:
the black/white cancer survival study. Obstet Gynecol. 1996 Dec;88(6):919-26.
Hirsch K, Danilenko M, et al. Effect of purified allicin, the major
ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr
Cancer. 2000;38(2):245-54.
Hofmeister FJ. Endometrial biopsy: another look. Am J Obstet Gynecol.
1974 Mar 15;118(6):773-7.
Horn-Ross PL, John EM, et al. Phytoestrogen intake and endometrial cancer
risk. J Natl Cancer Inst. 2003;95(15):1158-64.
Hu FB. Overweight and obesity in women: health risks and consequences. J
Womens Health (Larchmt). 2003 Mar;12(2):163-72.
Jacobs DR Jr, Meyer HE, et al. Consumption of whole grain foods and
chronic disease. Tidsskr Nor Laegeforen. 2004;124(10):1399-1401.
Jensen H. Relationship of premorbid state of nutrition to endometrial
carcinoma. Acta Obstet Gynecol Scand. 1986;65(4):301-6.
Juretzka MM, Chi DS, et al. Update on surgical treatment for endometrial
cancer. Expert Rev Anticancer Ther. 2005;5(1):113-21.
Kakizoe T. Chemoprevention of cancer: focusing on clinical trials. Jpn
J Clin Oncol. 2003 Sep;33(9):421-42.
Kao MS. Management of recurrent endometrial carcinoma. Chang Gung
Med J. 2004;27(9):639-45.
Kaur R, Sharma S, et al. Effect of sub-chronic selenium toxicosis on
lipid peroxidation, glutathione redox cycle and antioxidant enzymes in
calves. Vet Hum Toxicol. 2003 Aug;45(4):190-92.
Kedzia W. Analysis of steroid hormone receptors in endometrial cancer. Ginekol
Pol. 1996 May;67(5):254-58.
Key TJ, Pike MC. The dose-effect relationship between “unopposed” oestrogens
and endometrial mitotic rate: its central role in explaining and predicting
endometrial cancer risk. Br J Cancer. 1988 Feb;57(2):205-12.
Khorram O, Lessey BA. Alterations in expression of endometrial endothelial
nitric oxide synthase and alpha(v)beta(3) integrin in women with endometriosis. Fertil
Steril. 2002 Oct;78(4):860-64.
Kobayashi Y, Itoh MT , et al. Melatonin binding sites in estrogen receptor-positive
cells derived from human endometrial cancer. J Pineal Res. 2003;35(2):71-74.
Kris-Etherton PM, Harris WS, et al. Fish consumption, fish oil, omega-3
fatty acids, and cardiovascular disease. Circulation. 2002 Nov
19;106(21):2747-57.
La Vecchia C, Decarli A, et al. Nutrition and diet in the etiology of
endometrial cancer. Cancer. 1986;57(6):1248-53.
Lemay A, Dodin S, et al. Flaxseed dietary supplement versus hormone
replacement therapy in hypercholesterolemic menopausal women. Obstet
Gynecol. 2002 Sep;100(3):495-504.
Lenton KJ, Sane AT, et al. Vitamin C augments lymphocyte glutathione
in subjects with ascorbate deficiency. Am J Clin Nutr. 2003 Jan;77(1):189-95.
Levi F, Franceschi S, et al. Dietary factors and the risk of endometrial
cancer. Cancer. 1993;71(11):3575-81.
Lewis GC Jr, Slack NH, et al. Adjuvant progestogen therapy in the primary
definitive treatment of endometrial cancer. Gynecol Oncol. 1974
Aug;2(2-3):368-76.
Li CZ, Wen ZQ, et al. Study on the treatment of high dose mifepristone
and progesterone in endometrial carcinoma. Zhonghua Fu Chan Ke Za
Zhi. 2003 Sep;38(9):552-55.
Liao CK, Rosenblatt KA, et al. Endometrial cancer in Asian migrants
to the United States and their descendants. Cancer Causes Control.
2003 May;14(4):357-60.
Lipton LR, Johnson V, et al. Refining the Amsterdam Criteria and Bethesda
Guidelines: testing algorithms for the prediction of mismatch repair mutation
status in the familial cancer clinic. J Clin Oncol. 2004;22(24):4934-43.
Lissoni P, Chilelli M, et al. Five years survival in metastatic non-small
cell lung cancer patients treated with chemotherapy alone or chemotherapy
and melatonin: a randomized trial. J Pineal Res. 2003 Aug;35(1):12-5.
Lissoni P, Malugani F, et al. Total pineal endocrine substitution therapy
(TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic
solid tumor patients: a phase II study. Neuro Endocrinol Lett.
2003 Jun;24(3-4):259-62.
Littman AJ, Beresford SA, et al. The association of dietary fat and
plant foods with endometrial cancer ( United States ). Cancer Causes
Control. 2001;12(8):691-702.
Liu J, Burdette JE, et al. Evaluation of estrogenic activity of plant
extracts for the potential treatment of menopausal symptoms. J Agric
Food Chem. 2001 May;49(5):2472-9.
Longcope C, Pratt JH, et al. Aromatization of androgens by muscle and
adipose tissue in vivo. J Clin Endocrinol Metab. 1978 Jan;46(1):146-52.
Lord RS, Bongiovanni B, et al. Estrogen metabolism and the diet-cancer
connection: rationale for assessing the ratio of urinary hydroxylated
estrogen metabolites. Altern Med Rev. 2002;7(2):112-29.
Lotfallah H, Farag K, et al. One-stop hysteroscopy clinic for postmenopausal
bleeding. J Reprod Med. 2005;50(2):101-7.
Lotze W, Richter P, et al. High-dose progesterone therapy in advanced
endometrial cancer. Arch Geschwulstforsch. 1982;52(7):569-74.
Lou H, Wu R, et al. Relation between selenium and cancer of uterine
cervix. Zhonghua Zhong Liu Za Zhi. 1995;17(2):112-4.
Lucas EA, Wild RD , et al. Flaxseed improves lipid profile without altering
biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol
Metab. 2002 Apr;87(4):1527-32.
Lutz MH, Underwood PB Jr, et al. Endometrial carcinoma: a new method
of classification of therapeutic and prognostic significance. Gynecol
Oncol. 1978 Feb;6(1):83-94.
Magrina JF, Weaver AL. Laparoscopic treatment of endometrial cancer:
five-year recurrence and survival rates. Eur J Gynaecol Oncol.
2004;25(4):439-41.
Manusirivithaya S, Sripramote M, et al. Antiemetic effect of ginger
in gynecologic oncology patients receiving cisplatin. Int J Gynecol
Cancer. 2004 Nov;14(6):1063-9.
Mariani A, Dowdy SC, et al. High-risk endometrial cancer subgroups:
candidates for target-based adjuvant therapy. Gynecol Oncol.
2004 Oct;95(1):120-6.
Martin R, Kohler U, et al. Determination of steroid hormone receptors
with the biochemical DCC method in endometrial cancer and tumor margin-endometrium
relations to cellular changes and hormone level. Geburtshilfe Frauenheilkd.
1993 May;53(5):314-20.
McCann SE, Freudenheim JL, et al. Diet in the epidemiology of endometrial
cancer in western New York ( United States ). Cancer Causes Control.
2000;11(10):965-74.
McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene.
2004 Aug 23;23(38):6349-64.
McMeekin DS, Tillmanns T. Endometrial cancer: treatment of nodal metastases. Curr
Treat Options Oncol. 2003 Apr;4(2):121-30.
Meyskens FL Jr, Kopecky KJ, et al. Effects of vitamin A on survival
in patients with chronic myelogenous leukemia: a SWOG randomized trial. Leuk
Res. 1995 Sep;19(9):605-12.
Minagawa Y, Sato S, et al. Transvaginal ultrasonography and endometrial
cytology as a diagnostic schema for endometrial cancer. Gynecol Obstet
Invest. 2005;59(3):149-54.
Montgomery BE, Daum GS, et al. Endometrial hyperplasia: a review. Obstet
Gynecol Surv. 2004;59(5):368-78.
Montz FJ, Bristow RE, et al. Intrauterine progesterone treatment of
early endometrial cancer. Am J Obstet Gynecol. 2002 Apr;186(4):651-7.
Morrow CP, Bundy BN, et al. Relationship between surgical-pathological
risk factors and outcome in clinical stage I and II carcinoma of the endometrium:
a Gynecologic Oncology Group study. Gynecol Oncol. 1991 Jan;40(1):55-65.
Mourits MJ, De Vries EG, et al. Tamoxifen treatment and gynecologic
side effects: a review. Obstet Gynecol. 2001 May;97(pt 2):855-66.
Munstedt K, Grant P, et al. Cancer of the endometrium: current aspects
of diagnostics and treatment. World J Surg Oncol. 2004 Jul 21;2(1):24.
Murphy KT, Rotmensch J, et al. Outcome and patterns of failure in pathologic
stages I-IV clear-cell carcinoma of the endometrium: implications for
adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2003
Apr 1;55(5):1272-6.
Nagpal S. Retinoids: inducers of tumor/growth suppressors. J Invest
Dermatol. 2004 Dec;123(6):xx-xxi.
Nahum A, Hirsch K, et al. Lycopene inhibition of cell cycle progression
in breast and endometrial cancer cells is associated with reduction in
cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene.
2001;20(26):3428-36.
Nassar A, Fleisher SR, et al. Value of histiocyte detection in Pap smears
for predicting endometrial pathology: an institutional experience. Acta
Cytol. 2003;47(5):762-7.
Neumann F. The physiological action of progesterone and the pharmacological
effects of progestogens: a short review. Postgrad Med J. 1978;54(suppl
2):11-24.
Ng AB , Reagan JW, et al. Significance of endometrial cells in the detection
of endometrial carcinoma and its precursors. Acta Cytol. 1974
Sep;18(5):356-61.
Nishino H, Tokuda H, et al. Cancer prevention by antioxidants. Biofactors.
2004;22(1-4):57-61.
Noumoff JS, Faruqi S. Endometrial adenocarcinoma. Microsc Res Tech.
1993 Jun 15;25(3):246-54.
Ouzounian S, Christin-Maitre S. What is menopause? Rev Prat.
2005 Feb 28;55(4):363-8.
Pearce PT, Zois I, et al. Panax ginseng and Eleuthrococcus senticosus
extracts: in vitro studies on binding to steroid receptors. Endocrinol
Jpn. 1982 Oct;29(5):567-73.
Persson I, Adami HO, et al. Risk of endometrial cancer after treatment
with oestrogens alone or in conjunction with progestogens: results of
a prospective study. BMJ. 1989 Jan 21;298(6667):147-51.
Petridou E, Kedikoglou S, et al. Diet in relation to endometrial cancer
risk: a case-control study in Greece . Nutr Cancer. 2002;44(1):16-22.
Pike MC. Age-related factors in cancers of the breast, ovary, and endometrium. J
Chronic Dis. 1987;40(suppl 2):59S-69S.
Pike MC, Pearce CL, et al. Prevention of cancers of the breast, endometrium
and ovary. Oncogene. 2004 Aug 23;23(38):6379-91.
Piver MS. Progesterone therapy for malignant peritoneal cytology surgical
stage I endometrial adenocarcinoma. Semin Oncol. 1988 Apr;15(suppl
1):50-2.
Potischman N, Swanson CA , et al. Dietary associations in a case-control
study of endometrial cancer. Cancer Causes Control. 1993;4(3):239-50.
Power ML, Holzman GB, et al. Knowledge and clinical practice regarding
calcium nutrition among obstetrician-gynecologists. Obstet Gynecol.
1999 Sep;94(3):421-6.
Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract
Res Clin Obstet Gynaecol. 2001;15(3):341-54.
Reiter RJ. Mechanisms of cancer inhibition by melatonin. J Pineal
Res. 2004 Oct;37(3):213-4.
Robert Y, Launay S, et al. MRI in gynecology. J Gynecol Obstet Biol
Reprod ( Paris ) . 2002 Sep;31(5):417-39.
Salazar-Martinez E, Lazcano-Ponce E, et al. Dietary factors and endometrial
cancer risk: results of a case-control study in Mexico . Int J Gynecol
Cancer. 2005 Sep;15(5):938-45.
Sanchez-Barcelo EJ, Cos S, et al. Melatonin-estrogen interactions in
breast cancer. J Pineal Res. 2005 May;38(4):217-22.
Schaafsma G. The scientific basis of recommended dietary allowances
for calcium. J Intern Med. 1992 Feb;231(2):187-94.
Schapira DV. Nutrition and cancer prevention. Prim Care. 1992;19(3):481-91.
Sevelda P, Salzer H. Hormones and cancer: risk-benefit. Gynakol
Geburtshilfliche Rundsch. 1998;38(2):61-3.
Shu XO, Zheng W, et al. A population-based case-control study of dietary
factors and endometrial cancer in Shanghai , People's Republic of China
. Am J Epidemiol. 1993;137(2):155-65.
Simonneaux V, Ribelayga C. Generation of the melatonin endocrine message
in mammals: a review of the complex regulation of melatonin synthesis
by norepinephrine, peptides, and other pineal transmitters. Pharmacol
Rev. 2003 Jun;55(2):325-95.
Sivridis E, Giatromanolaki A. Prognostic aspects on endometrial hyperplasia
and neoplasia. Virchows Arch. 2001 Aug;439(2):118-26.
Sivridis E, Giatromanolaki A. Endometrial adenocarcinoma: beliefs and
scepticism. Int J Surg Pathol. 2004 Apr;12(2):99-105.
Soliman PT, Oh JC, et al. Risk factors for young premenopausal women
with endometrial cancer. Obstet Gynecol. 2005 Mar;105(3):575-80.
Spencer TE, Bazer FW. Biology of progesterone action during pregnancy
recognition and maintenance of pregnancy. Front Biosci. 2002
Sep 1;7:d1879-d1898.
Steinmetz KA, Potter JD. Vegetables, fruit, and cancer, II: mechanisms. Cancer
Causes Control. 1991 Nov;2(6):427-42.
Stenchever MA, Droegemueller W, et al. Comprehensive Gynecology. 4th
edition. Philadelphia , Pa : Elsevier Health Sciences; 2002.
Sundstrom H. Annual variation of serum selenium in patients with gynaecological
cancer during 1978-1983 in Finland : a low selenium area. Int J Vitam
Nutr Res. 1985;55(4):433-8.
Sundstrom H, Korpela H, et al. Supplementation with selenium, vitamin
E and their combination in gynaecological cancer during cytotoxic chemotherapy. Carcinogenesis.
1989;10(2):273-8.
Sundstrom H, Ylikorkala O, et al. Serum selenium and thromboxane in
patients with gynaecological cancer. Carcinogenesis. 1986;7(7):1051-2.
Sundstrom H, Yrjanheikki E, et al. Low serum selenium concentration
in patients with cervical or endometrial cancer. Int J Gynaecol Obstet.
1984 Feb;22(1):35-40.
Swerdlow AJ, Jones ME. Tamoxifen treatment for breast cancer and risk
of endometrial cancer: a case-control study. J Natl Cancer Inst.
2005;97(5):375-84.
Tamayo C, Richardson MA . Vitamin C as a cancer treatment: state of
the science and recommendations for research. Altern Ther Health Med.
2003 May;9(3):94-101.
Tanaka S, Haruma K, et al. Effects of aged garlic extract ( AGE ) on
colorectal adenomas: a double-blinded study. Hiroshima J
Med Sci . 2004;53(3-4):39-45.
Terry P, Baron JA, et al. Lifestyle and endometrial cancer risk: a cohort
study from the Swedish Twin Registry. Int J Cancer. 1999;82(1):38-42.
Terry P, Vainio H, et al. Dietary factors in relation to endometrial
cancer: a nationwide case-control study in Sweden . Nutr Cancer.
2002;42(1):25-32.
Thurzo L. Response of estrogen and progesterone receptors to treatment
with large doses of progestogen (depo-provera) in endometrial cancer. Zentralbl
Gynakol. 1990;112(17):1111-5.
Urbanski K, Karolewski K, et al. Adjuvant progestagen therapy improves
survival in patients with endometrial cancer after hysterectomy: results
of one-institutional prospective clinical trial. Eur J Gynaecol Oncol.
1993;14(suppl):98-104.
Warren MP, Shantha S. Uses of progesterone in clinical practice. Int
J Fertil Womens Med. 1999 Mar;44(2):96-103.
Wiklund IK, Mattsson LA, et al. Effects of a standardized ginseng extract
on quality of life and physiological parameters in symptomatic postmenopausal
women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine
Group. Int J Clin Pharmacol Res. 1999;19(3):89-99.
Willett WC. Diet and cancer: an evolving picture. JAMA. 2005;293(2):233-34.
Xu WH, Zheng W, et al. Soya food intake and risk of endometrial cancer
among Chinese women in Shanghai : population based case-control study. BMJ.
2004 May;328(7451):1285.
Yahata H, Hirakawa T, et al. Postoperative adjuvant chemotherapy with
cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin,
pirarubicin) for endometrial cancer. Int J Clin Oncol. 2004 Aug;9(4):317-21.
Yang G, Zhou R. Further observations on the human maximum safe dietary
selenium intake in a seleniferous area of China . J Trace Elem Electrolytes
Health Dis. 1994 Dec;8(3-4):159-65.
Yuan CS, Wei G, et al. Brief communication: American ginseng reduces
warfarin's effect in healthy patients: a randomized, controlled trial. Ann
Intern Med. 2004 Jul 6;141(1):23-7.
Zhao L, Zhao W, et al. Correlation of the metabolism of oxygen free
radical in ovary, uterine muscle and vein blood with the pathogenesis
of endometriosis or endometrioma. Zhonghua Fu Chan Ke Za Zhi.
2001 May;36(5):299-301.